WASHINGTON--(BUSINESS WIRE)--In an MDLinx (www.mdlinx.com) survey conducted of more than 2400 U.S. physicians this past week, 72.6 percent of respondents reported experiencing a higher volume of flu symptoms in their patients than normal for this time of the season, with 22.6 percent reporting more patients at this point in the season than at any point in their medical careers. Just over seventy percent of pediatricians reported their flu patient volume as higher than normal. Forty three percent of pediatricians reported experiencing shortages of vaccine in their practice and 46.2 percent said they had reports from their patients of an inability to fill prescriptions for the popular antiviral medicines. MDLinx, a web property of M3 USA (http://usa.m3.com) is the nation’s leading specialty physician portal.
“Doctors in each region of the U.S. reported above average numbers of patients and severity of symptoms for this point in the season,” said Aki Tomaru, president of M3 USA. “Shortages of antivirals were most severe in the Northeast, with 45 percent of doctors reporting patients complaining of an inability to fulfill antiviral prescriptions.” The survey, conducted January 15-19, polled 2,430 practicing U.S. physicians in the areas of family medicine, pediatrics, internal medicine, general practice, and emergency medicine.
Emergency physicians also reported high volumes, with 80.5 percent reporting more patients than usual for this time of the season, and 30.5 percent reporting the highest in their experience. “Very aggressive onset and early arrival,” said one. “This year, it spreads faster and hits harder than usual,” said another emergency doctor.
Pediatricians seemed to be particularly hard hit, with 43 percent reporting vaccine shortages in their practices. One New York doctor said the public health emergency declared there, which allowed pharmacists to administer vaccines to children, has been problematic. “The governor allowed pharmacists to give vaccines to little children, but the pharmacists are all scared to do so and asking us for verbal okays to give the vaccine,” said the pediatrician. “We are being swamped with requests to okay giving vaccines to patients whom we have not seen.”
About M3 USA
M3 USA is part of M3, Inc., a publicly traded company on the Tokyo Stock Exchange. M3 USA, named to represent Medicine, Media, and Metamorphosis, was founded with the goal of changing the world of medicine through full use of the power of the Internet. M3 provides the life science industry with highly targeted interactive marketing, education, content, and research solutions. Through these means, we help healthcare professionals provide the best care by enabling them to stay current on the ever-evolving practice of medicine. In 2006, we started our service in the US through the acquisition of MDLinx, now the nation’s leading specialty physician portal and provider of online marketing solutions to the life sciences industry.
MDLinx (www.mdlinx.com) is an award-winning, practical medical information tool used by busy physicians and healthcare professionals to stay up to date with the latest research in the medical field. On a daily basis, the company’s physician editors read, rank and sort published data and research from leading news media and more than 1,300 peer-reviewed journals in 35 specialties. MDLinx’s content and services are provided at no charge to member physicians. MDLinx is a web property of M3 USA, http://usa.m3.com, which offers information solutions to healthcare providers and industry.